BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11186000)

  • 1. Hydroxyurea-induced fever in a patient with chronic myelogenous leukemia.
    Tsurumi H; Goto H; Hara T; Moriwaki H
    Int J Hematol; 2000 Oct; 72(3):386-7. PubMed ID: 11186000
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
    Tripathi AK; Ahmad R; Sawlani KK
    J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea induced leg ulcers.
    Abhyankar D; Shende C; Saikia T; Advani SH
    J Assoc Physicians India; 2000 Sep; 48(9):926-7. PubMed ID: 11198798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
    Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
    Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leukemia, cytostatic therapy and pregnancy].
    Jakó J
    Orv Hetil; 1994 Jan; 135(1):43. PubMed ID: 7779171
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anhidrosis during long-term hydroxyurea therapy in a patient with chronic myelogenous leukemia].
    Takagi K; Nakamura T; Misaki H; Ueda T
    Rinsho Ketsueki; 2000 Nov; 41(11):1214-9. PubMed ID: 11193442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Symmetrical foot ulcer in chronic myeloid leukemia treated with hydroxyurea (Litalir)].
    Reichenberger F
    Praxis (Bern 1994); 1998 Oct; 87(41):1370-2. PubMed ID: 9828669
    [No Abstract]   [Full Text] [Related]  

  • 8. Perimalleolar ulcers in hydroxyurea treated patients with concomitant chronic venous disease: diagnostic pitfalls.
    Jain V; Gupta K; Nagpal N
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):658-60. PubMed ID: 19810313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of drug-induced colitis complicating the administration of hydroxycarbamide.
    Sadamoto Y; Ueda T; Matsumoto M; Kubokawa M; Ito K; Kubo H; Tanaka M; Harada N; Muta K; Nawata H; Takata M; Yao T
    Endoscopy; 2002 Jun; 34(6):511. PubMed ID: 12048644
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bilateral leg ulcers with pathologic evidence of small vessel vasculitis by skin biopsy during hydroxyurea therapy of chronic myelogenous leukemia].
    Tomiyama J; Yano K; Uchino S; Ito T; Kudo H; Irimajiri J; Ohkubo H; Kanazawa A; Kawahara Y
    Rinsho Ketsueki; 1997 Mar; 38(3):231-3. PubMed ID: 9095664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nail changes in a patient with leukaemia.
    Bhaskar ME
    BMJ; 2011 Jan; 342():c6439. PubMed ID: 21224311
    [No Abstract]   [Full Text] [Related]  

  • 12. Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.
    Leo E; Krämer A; Hochhaus A; Krasniqi F; Hehlmann R; Ho AD
    Ann Hematol; 2002 Aug; 81(8):467-9. PubMed ID: 12224005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous complications of long-term hydroxyurea therapy].
    Dem A; Diallo M; Gaye Fall MC; Dieng MM; Gaye M; Touré P
    Ann Dermatol Venereol; 2008 Nov; 135(11):800-1. PubMed ID: 19061670
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe hyponatremia with consciousness disturbance caused by hydroxyurea in a patient with chronic myeloid leukemia].
    Watanabe N; Tani M; Tanaka Y; Kurata M; Matsushita A; Maeda A; Nagai K; Takahashi T
    Rinsho Ketsueki; 2004 Mar; 45(3):243-6. PubMed ID: 15103940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [National guidelines for treatment of chronic myelogenous leukemia].
    Wisløff F; Brinch L; Hammerstrøm J
    Tidsskr Nor Laegeforen; 2003 Jan; 123(2):157-9. PubMed ID: 12607495
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple squamous cell carcinomas of the skin during long-term treatment with hydroxyurea.
    De Simone C; Guerriero C; Guidi B; Rotoli M; Venier A; Tartaglione R
    Eur J Dermatol; 1998 Mar; 8(2):114-5. PubMed ID: 9649662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea treatment for chronic myeloid leukemia during pregnancy.
    Celiloglu M; Altunyurt S; Undar B
    Acta Obstet Gynecol Scand; 2000 Sep; 79(9):803-4. PubMed ID: 10993110
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myositis caused by hydroxyurea in a patient with chronic myelogenous leukemia].
    Ikeda K; Mita M; Ishibashi T; Shichishima T; Maruyama Y
    Rinsho Ketsueki; 1998 Sep; 39(9):676-9. PubMed ID: 9796402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bilateral ankle ulcers associated with hydroxyurea therapy for chronic myelogenous leukemia].
    Masuoka H; Kobayashi M; Kaito K; Yoshida M; Sekita T; Saeki A; Nishiwaki K; Shimada T; Ochiai S; Ootsubo H
    Rinsho Ketsueki; 1995 Feb; 36(2):156-8. PubMed ID: 7715088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Longitudinal melanonychia and hydroxyurea].
    Pirard C; Michaux JL; Bourlond A
    Ann Dermatol Venereol; 1994; 121(2):106-9. PubMed ID: 7979014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.